thermo fisher weather current storm better
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
bigger alway better thermo fisher nonetheless
maintain torrid pace acquisit ultim goal
becom go-to provid life scienc instrument
consum recent acquir affymetrix fei patheon
process ad portfolio
remain cautiou regard growth-via-acquisit strategi
yet see evid billion compani
spent acquisit sinc exlud yield
benefit return invest capit
acquisit strategi allow firm significantli
broaden product offer turn allow steadili
gain market share one-stop shop approach afford price
flexibl result strong custom relationship
compani find recept audienc larg pharma client
see sizabl benefit simplifi procur process
thermo fisher offer result firm penetr pharma
expand expect continu even see
deceler biopharma spend growth current level
thermo fisher emerging-market presenc also impress
grow rapidli total sale firm
significantli expand manufactur footprint area
allow compet effect indigen manufactur
brand carri power among research given
on-going commit research particularli life scienc
emerging-market govern compani goal expand
emerging-market busi annual appear
firm effort yield organ market share gain
core strategi remain growth acquisit
aggress clearli state capital-deploy strategi
remain risk firm could overpay yet anoth sizabl
deal fuel cheap financ said ever-expand
presenc virtual area life scienc research part
achiev acquisit afford thermo fisher opportun
capit strong secular growth expect sector
next decad
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
thermo fisher scientif sell scientif instrument laboratori
equip diagnost consum life scienc reagent firm
includ
cross-seg revenu analyt technolog sale specialti
diagnost product life scienc solut lab product
servic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
rais fair valu estim per share
due mainli cash flow realiz sinc previou
report includ modest neg impact
compani result forecast although much
neg hit revenu line capital-intens
instrument side mitig on-going solid
growth recur revenu line
organ growth expect core busi
approxim admittedli highli
uncertain part depend util
compani diagnost test howev thermo
fisher rather insul recessionari spend
pullback one quarter revenu classifi
instrument equip consid
discretionari long term continu expect
steadi growth biopharma spend stabl demand
academ govern custom particularli
unit state healthi perform industri end
market long-term expect double-digit growth
emerg market need off-set much matur
inflationlik growth develop world anticip
modest benefit acquisit
long term forecast thermo fisher sale
exclud expect analyt instrument
life scienc segment drive futur growth
matur catalog busi provid cash flow fund
invest growth area anticip thermo fisher
adjust oper margin exclud amort
improv basi point next five year line
firm
manufactur shift lower-cost region effici
improv off-set price pressur
mani commod product
impact pronounc
recessionari period lengthier expect
compani key end market biopharma hard land
develop world china deceler fair valu
estim fall per share thermo fisher knack
cost control challeng growth environ
also propens supplement intern growth
acquisit henc growth environ remain
constrain compani could opt becom aggress
acquisit front provid addit risk
length sever recess also one
variabl bull case overal impact valuat
signific thermo fisher expect cede
ground competit opportun captur
even greater wallet share post-downturn period
pharmaceut spend reacceler compani
maintain mid-single-digit growth develop market
china deliv double-digit growth throughout forecast
signific upsid valuat posit
scenario valu compani per share
thermo fisher narrow moat come scale
scope busi -- enorm manufactur sale
infrastructur along broad product
offer rang scientif instrument lab
equip softwar servic steadi consolid
variou busi
instrument fisher catalog phadia dionex
life affymetrix fei patheon pend
acquisit allow compani market
one-stop shop research custom appeal
featur laboratori look simplifi procur
function addit life patheon
compani consum servic busi even
massiv account total sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
persist gener return invest capit
excess cost primarili owe acquisit strategi
opt includ acquisit associ goodwil
assumpt
on-going capit deploy
requir compani use acquisit
supplement intern research develop
deal size grow larger thermo fisher increasingli
face scenario deploy capit value-dilut
manner particularli interest rate increas
thermo fisher moat widen compani
low-cost posit rais
custom compani
distribut network alreadi far largest
offer scale advantag competit continu
grow rapidli particularli low-cost manufactur
area compani strong on-the-ground presenc
china coupl alreadi well-establish bond
multi-national compani expand
market allow capit market
rapid growth also cement tight relationship
custom unlik larg instrument maker
larger compani instal base stronger
competit advantag equip busi due
switch cost high-margin recur revenu stream
final increas abil offer custom
complet solut procur need allow
thermo fisher gradual muscl smaller peer
even gain ground larger organ
come wallet share particularli among main
entrench custom base autom inventori
manag across broad array product strong
sell point compani compani access
custom channel unparallel legaci fisher catalog
domin marketplac next-largest competitor
significantli smaller presenc
also afford firm massiv cross-sel opportun
thermo fisher salesforc also far largest
industri allow compani penetr
emerg market final distribut network give
thermo fisher also domin posit within
signific switch cost result costli
up-front invest equip exceed
million train instal instrument
requir recur stream consum purchas
servic revenu therebi insul thermo fisher
full brunt capit cycl competitor pressur
hesit award thermo fisher wide econom moat
larg lack confid compani abil
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth firm target market approxim billion
largest supplier research instrument
aggress acquir
compani expans strategi depend heavili
success acquisit earn number
pollut signific non-gaap adjust
othermo fisher among industri leader nearli
ubiquit research lab across globe
oth compani track record effect
excel particularli mass spectrometri
one global leader base larg home-
firm diagnost busi struggl
gener momentum legaci phadia
busi strong foothold europ overal
growth subpar
oth compani abl fuel acquisit spree via
access extrem inexpens debt gener
excess return acquisit less favor
interest rate environ might challeng
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
end thermo fisher carri billion long-
short-term debt time ebitda held
billion cash balanc sheet number
includ debt issuanc pertain billion qiagen
acquisit acquisit fei affymetrix
patheon delay manag goal achiev target
leverag time within month complet
life technolog acquisit compani
nonetheless quit quick pay debt manag
state past would will boost debt
leverag time right opportun
even debt issuanc fund still
threshold compani gener robust cash
flow concern regard solvenc minim
furthermor compani cash flow rather
predict consum servic account
major total sale anticip thermo fisher
remain aggress acquisit share buyback
compani pay dividend rather small rel
free cash flow
thermo fisher weather storm
better peer firm still like feel pinch
econom downturn firm exposur industri end
market increas vulner prolong
recess fei semiconductor busi particular could
sever affect industri spend peak
cycl current declin
compani key
environment instrument target market -- china
india -- reduc environment qualiti test due
fiscal concern currenc headwind could
off-set thermo recoveri life scienc market
analyt
instrument busi particularli low-end instrument
manufactur thermo also depend research activ
academia govern could advers
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
affect delay fund feder nation
institut busi signific risk
technolog nascent final acquisit strategi
continu expos firm risk overpay
increasingli larger acquisit inabl integr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
acknowledg manag solid track record
acquisit strategi test
pend deal note serial
acquir yet produc meaning return invest
capit access cheap financ fuel recent buy
spree interest see whether chase
earn per share growth backfir rate eventu
rise think manag team fare well
integr numer acquisit deploy cash
flow value-accret way success integr
increasingli larger fairli expens acquisit
signific challeng ceo marc casper team
compani suggest return capit metric
discuss frequent late improv
next five year howev chronic acquisit make
promis rather murki see opportun
continu drive margin improv intern
improv synergi ignor dilut
impact acquisit believ continu
return compani emphasi adjust ep
obscur realiti acquisit play role
ceo/chairman board/
repres date owner name posit common share held report holder issuer
american fund growth fund amer
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
thermo fisher acquir qiagen billion
rumor circul late last year discuss
thermo fisher scientif note
would opportun time serial acquir like
thermo fisher pick compani midst
chang announc march agreement
two board director target
valuat stand-alon intrins valuat
anticip deal close plan
first half expect rais fair valu
estim match offer eur per share per
share current exchang rate anticip
materi chang fair valu estim narrow moat
rate thermo fisher deal cheap
price differenti roughli equival valu
synergi anticip thermo fisher deliv
specul thermo fisher plan regard
special diagnost divis sever year unlik
segment busi larg under-perform
receiv materi invest form
acquisit particular signific
diseas fit thermo fisher need although growth
especi late lacklust also
provid complementari product portfolio genet
analysi segment thermo fisher vow
bolster integr product thermo
fisher channel rather seamless million
revenu synergi appear realist
compani target million oper synergi
probabl come sale administr
expens well tax thermo fisher shrewd
lean oper record extract cost synergi
deal anticip transact
approxim neutral return invest capit
assum cost save materi
thermo fisher deliv fourth quarter share
thermo fisher scientif report fourth-quart result
line expect revenu
organ basi year year adjust oper
margin roughli flat compani guidanc call
report revenu growth earn growth
forecast fall rang
maintain fair valu estim believ share
overvalu current level narrow-moat rate
pharmaceut biotech channel perform
strongli revenu growth quarter though
growth moder compani still grow
faster overal industri gain share
diagnost busi continu show progress good
growth transplant diagnost immunodiagnost
analyt segment bit fourth quarter
larg expect due tough comparison
microscopi busi deliv superb
china surprisingli light quarter low singl
digit thermo fisher blame govern decis
releas slowli capit spend fund compani
account effect right relat
coronaviru thermo fisher could potenti
adjust oper margin basi point
due volum effect product gain
partial off-set product mix
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
thermo fisher scientif report third-quart result
line market expect revenu
billion organ basi year year
adjust oper margin expand basi point
compani rais revenu ep
guidanc slightli forecast within updat
rang like rais fair valu estim
result time valu money believ share
overvalu current level
pharmaceut biotech channel
perform strongli double-digit revenu growth
quarter though growth moder
compani still grow faster overal industri
integr brammer track although manag
expect volatil viral vector industri
earli stage channel compani also complet
acquisit api ingredi manufactur facil
glaxosmithklin industri appli
segment growth flat high compar
basi quarter last year academ
govern divis diagnosi healthcar
divis deliv mid- high-single-digit growth rate
respect latter driven good perform
transplant diagnost immunodiagnost region
china keep grow moder pace
revenu europ north america grew
high midsingl digit respect
adjust oper margin basi point
due volum effect product gain
partial off-set product mix
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
